May 3, 2019 - May 8, 2019

Par Drugs IPO Subscription Details

Par Drugs IPO Subscription Status Live

Par Drugs IPO subscribed 5.74 times. The public issue subscribed 7.97 times in the retail category, 3.48 times in Other category by May 8, 2019.

Investor Category	Subscription (times)	Shares Offered	Shares Bid for	Total Amount (Rs Cr.)*
Others	3.48	778,000	27,06,000	13.80
Retail Investors	7.97	780,000	62,14,000	31.69
Total	5.74	1,558,000	89,50,000	45.65

Disclaimer: *The total amount is calculated based on the final issue price or the price in the upper price range.

* Market Maker portion of 84,000 equity shares not included.

Par Drugs IPO (Day-wise) Subscription Details (times)

Date	Other	Retail	EMP	Total
Day 1 May 3, 2019	0.23	0.15	1.00	0.21
Day 2 May 6, 2019	0.61	0.79	1.00	0.72
Day 3 May 7, 2019	0.89	1.85	1.00	1.39
Day 4 May 8, 2019	3.48	7.97	1.00	5.74

Par Drugs IPO Shares Offered

Par Drugs IPO is a public issue of 1,642,000 equity shares. The issue offers 780,000 shares to retail investors, 778,000 shares to other investors. The other investors include applicants other than retail i.e. HNI, corporates, institutions, (NII and QIB).

Category	Shares Offered	Amount (Rs Cr)	Size (%)
Market Maker	84,000	0.43	5.12%
Other	778,000	3.97	47.38%
Retail	780,000	3.98	47.50%
Employee	30,000	0.15	1.83%
Total	1,642,000	8.37	100%

IPO Investor Categories

Qualified Institutional Buyers (QIB)
Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.
Non-Institutional Investors(NII)
Retail Individual Investors (HNI), NRIs, Companies, Trusts, etc who bid for shares worth more than Rs 2 lakhs are known as Non-institutional bidders (NII). Unlike QIB bidders, they do not need SEBI registration.
NII category has two subcategories:
1. sNII (bids below Rs 10L)
  The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category. This subcategory is also known as Small HNI (sHNI).
2. bNII (bids above Rs 10L)
  The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory. This subcategory is also known as Big HNI (bHNI).
Retail Individual Investors(RII)
The retail individual investor or NRIs who apply up to Rs 2 lakhs in an IPO are considered as RII reserved category.
Employee (EMP)
A category of eligible employees who have a reserved quota in the IPO.
Others
A category of eligible shareholders or other investors who have a reserved quota in the IPO.

What is the difference between RII, NII, QIB and Anchor Investor?

Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided here in is for informational purposes only and is provided by Chittorgarh.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. Chittorgarh.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. Chittorgarh.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. Chittorgarh.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.

Par Drugs IPO Subscription FAQs

The Par Drugs IPO is subscribed 5.74 by May 8, 2019.